- Trials with a EudraCT protocol (100)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
100 result(s) found for: Drug education.
Displaying page 1 of 5.
EudraCT Number: 2006-001468-21 | Sponsor Protocol Number: KIIOIW001 | Start Date*: 2006-08-24 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Sympthomatic and prophylactic treatment of drug induced oral dryness in elderly patients with high drug consumption. | ||
Medical condition: Oral dryness is a common problem with serious consquences, especially among elderly individuals. The most common reason for oral dryness is drug consumption. Research has shown that an individual w... | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-002780-30 | Sponsor Protocol Number: 9515 | Start Date*: 2022-12-01 | |||||||||||
Sponsor Name:Aarhus University Hospital, The Research Clinic for Functional Disorders and Psychosomatics | |||||||||||||
Full Title: Efficacy of patient education and duloxetine, alone and in combination, for patients with multiorgan bodily distress syndrome: a partial-factorial randomized controlled trial (the EDULOX-trial) | |||||||||||||
Medical condition: Multiorgan Functional somatic disorders (FSD) / bodily disstress syndrome (BDS) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002147-34 | Sponsor Protocol Number: AZT-001 | Start Date*: 2016-01-21 | |||||||||||
Sponsor Name:AZTherapies, Inc. | |||||||||||||
Full Title: A phase III Safety and Efficacy Study of ALZT-OP1 in Subjects with Evidence of Early Alzheimer’s Disease. | |||||||||||||
Medical condition: Early stage of Alzheimer's Disease. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BG (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005544-79 | Sponsor Protocol Number: Beau_Resp_05_001 | Start Date*: 2006-03-24 |
Sponsor Name:The Clinical Research Centre, RCSI Education and Research Centre | ||
Full Title: Adalimumab (Humira) as add-on therapy in the treatment of patients with severe persistent therapy resistant asthma | ||
Medical condition: Severe Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2009-010067-16 | Sponsor Protocol Number: CN156018 | Start Date*: 2009-07-08 | |||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Effects of BMS-708163 in the Treatment of Patients with Prodromal ... | |||||||||||||
Medical condition: ALZHEIMER DISEASE | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) NL (Completed) FR (Completed) DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000087-42 | Sponsor Protocol Number: TAISTR_2016 | Start Date*: 2016-05-11 |
Sponsor Name:University College Dublin | ||
Full Title: A multicentre, prospective, single arm, open-label 96 week observational trial of the tolerability, adherence and efficacy of a dolutegravir/abacavir/lamivudine single tablet regimen in HIV-1 antib... | ||
Medical condition: Human Immunodeficiency Virus (HIV) infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Prematurely Ended) ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2008-001881-10 | Sponsor Protocol Number: RAPHAEL study | Start Date*: 2008-05-27 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: Raltegravir/Atazanavir pharmacokinetics and evaluation of lipids | |||||||||||||
Medical condition: chronic HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004527-32 | Sponsor Protocol Number: SITADS | Start Date*: 2016-11-22 | ||||||||||||||||
Sponsor Name:King's College London [...] | ||||||||||||||||||
Full Title: Pilot randomised controlled trial of SITAgliptin for Depressive Symptoms in type 2 diabetes | ||||||||||||||||||
Medical condition: Depression in type 2 diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-005538-59 | Sponsor Protocol Number: 22-09-2008 | Start Date*: 2009-02-18 |
Sponsor Name:ZonMw | ||
Full Title: Impulsivity, a risk factor in relapse to substance use disorder: investigating neural substrates before and after pharmacological challenges | ||
Medical condition: Alcohol dependence Cocaine dependence | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001331-26 | Sponsor Protocol Number: PROLIFIC2020 | Start Date*: 2020-04-14 | |||||||||||
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | |||||||||||||
Full Title: ChemoPROphyLaxIs For covId-19 infeCtious disease (the PROLIFIC trial) | |||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19) caused by the infection, SARS-CoV-2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001995-20 | Sponsor Protocol Number: 2205p | Start Date*: 2011-03-14 |
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | ||
Full Title: A pilot study on educational aproach to improve compliance to medical precriptions in transplantation recipients. | ||
Medical condition: Patients who underwent liver or renal transplantation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001232-42 | Sponsor Protocol Number: RGHT000270 | Start Date*: 2006-06-14 |
Sponsor Name:Royal Group of Hospitals Trust | ||
Full Title: The Pharmacogenetics of Aspirin Resistance | ||
Medical condition: Aspirin resistance: Vascular diseases are common problems and aspirin is used as an anti-platelet drug to prevent thrombosis. However, aspirin's anti-platelet effect may not be uniform in all patie... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-014656-30 | Sponsor Protocol Number: CARDS Study | Start Date*: 2009-07-31 |
Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | ||
Full Title: Combination of Atazanavir and Raltegravir as Dual Strategy | ||
Medical condition: Documented HIV infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004554-32 | Sponsor Protocol Number: PC_ASP_006 | Start Date*: 2022-07-09 | |||||||||||
Sponsor Name:Pulmocide Ltd | |||||||||||||
Full Title: A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added to systemic antifungal therapy for the treatment of refractory invasive pulmonar... | |||||||||||||
Medical condition: Refractory invasive pulmonary aspergillosis (IPA) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) ES (Ongoing) IT (Trial now transitioned) AT (Trial now transitioned) GR (Trial now transitioned) BE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004149-17 | Sponsor Protocol Number: 40346527ALZ1001 | Start Date*: 2019-06-07 | |||||||||||
Sponsor Name:University of Oxford / Clinical Trials and Research Governance | |||||||||||||
Full Title: A randomised, placebo-controlled, single-blind study to characterise the biomarker effects of the CSF-1 receptor antagonist JNJ-40346527 in participants with mild cognitive impairment | |||||||||||||
Medical condition: Mild Cognitive Impairment | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-003745-11 | Sponsor Protocol Number: 1346-0014 | Start Date*: 2024-03-02 | |||||||||||
Sponsor Name:Boehringer Ingelheim | |||||||||||||
Full Title: An open label, single arm, extension trial to examine long-term safety of BI 425809 once daily in patients with schizophrenia who have completed previous BI 425809 Phase III trials.(CONNEX-X) | |||||||||||||
Medical condition: Schizophrenia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) CZ (Trial now transitioned) ES (Ongoing) SK (Trial now transitioned) HU (Trial now transitioned) NO (Trial now transitioned) DK (Trial now transitioned) LT (Trial now transitioned) IT (Trial now transitioned) GR (Trial now transitioned) BE (Trial now transitioned) SE (Trial now transitioned) NL (Trial now transitioned) FI (Trial now transitioned) HR (Trial now transitioned) AT (Trial now transitioned) BG (Trial now transitioned) PT (Trial now transitioned) RO (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001354-95 | Sponsor Protocol Number: 149/11 | Start Date*: 2013-06-13 | |||||||||||
Sponsor Name:Keele University | |||||||||||||
Full Title: A randomised, multi-centre, open-label, active-comparator, pragmatic clinical trial of low-dose colchicine versus naproxen in patients with acute gout. | |||||||||||||
Medical condition: Acute Gout | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-001862-16 | Sponsor Protocol Number: 1.7 | Start Date*: 2013-06-05 | |||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | |||||||||||||
Full Title: Randomised controlled pilot study: Does intraoperative clonidine reduce the incidence of post-hospitalisation negative behaviour changes in children who are distressed during the induction of gener... | |||||||||||||
Medical condition: Behaviour | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002505-74 | Sponsor Protocol Number: CEP1538/3034/ES/MN | Start Date*: 2005-01-05 | |||||||||||
Sponsor Name:Cephalon Europe, A Division of Cephalon UK Limited | |||||||||||||
Full Title: A 6 month open-label, flexible-dosage study to assess the safety and effectiveness of PROVIGIL® (Modafinil) treatment in children and adolescents with excessive sleepiness associated with narcoleps... | |||||||||||||
Medical condition: Excessive sleepiness associated with Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) FI (Completed) GB (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-000078-19 | Sponsor Protocol Number: CH/2006/2401 | Start Date*: 2009-03-25 | |||||||||||
Sponsor Name:University Hospitals Bristol NHS Foundation Trust | |||||||||||||
Full Title: Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation | |||||||||||||
Medical condition: Patients must be admitted to PICU and are likely to require intubation and ventilation for more than 48 hours. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
